BIOA Stock Analysis: Buy, Sell, or Hold?
BIOA - BioAge Labs, Inc. Common Stock
$18.99
-0.11 (-0.58%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When BIOA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BIOA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BIOA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BIOA is currently trading at $18.99, which is considered slightly high relative to its 30-day fair value range of $13.21 to $19.78.
Technical Outlook: Technically, BIOA is in a strong uptrend. Immediate support is located at $18.20, while resistance sits at $21.53.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $12.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BIOA is in a strong uptrend. Immediate support is located at $18.20, while resistance sits at $21.53.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $12.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$13.21 -
$19.78
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
Protect Your Profits
Holding BIOA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 36.8% above Wall St target ($12.00)
Fair Price Analysis
30-Day Fair Range
$13.21 -
$19.78
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$18.20
Resistance Level
$21.53
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-6.75
Wall Street Target
$12.00
(-36.8%)
Last updated: February 01, 2026 4:53 AM ET
Data refreshes hourly during market hours. Next update: 5:53 AM
Data refreshes hourly during market hours. Next update: 5:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced BIOA Option Strategies
Professional options setups generated by AI based on today's BIOA price and gamma walls.
